| Nome |
# |
|
Monoclonal antibodies for treating osteoporosis, file 35edbb41-01cb-45d4-99fe-2e2c282aea9b
|
146
|
|
Osteogenic differentiation of mesenchymal stem cells from dental bud: Role of integrins and cadherins, file dd9e0c64-479f-1e9c-e053-3a05fe0a45ef
|
84
|
|
Functions of vasopressin and oxytocin in bone mass regulation, file dd9e0c64-51d8-1e9c-e053-3a05fe0a45ef
|
81
|
|
Impairment of bone remodeling in LIGHT/TNFSF14-deficient mice, file dd9e0c65-3922-1e9c-e053-3a05fe0a45ef
|
77
|
|
The myokine irisin increases cortical bone mass, file dd9e0c64-5249-1e9c-e053-3a05fe0a45ef
|
75
|
|
Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α, file 72846c0d-b495-4be7-a979-4d8702d419b4
|
74
|
|
Effects of sweet cherry polyphenols on enhanced osteoclastogenesis associated with childhood obesity, file dd9e0c65-a3c3-1e9c-e053-3a05fe0a45ef
|
73
|
|
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens, file dd9e0c65-6c86-1e9c-e053-3a05fe0a45ef
|
69
|
|
Irisin serum levels are positively correlated with bone mineral status in a population of healthy children, file dd9e0c66-6297-1e9c-e053-3a05fe0a45ef
|
68
|
|
Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice, file dd9e0c64-448b-1e9c-e053-3a05fe0a45ef
|
67
|
|
Irisin and Bone: From Preclinical Studies to the Evaluation of Its Circulating Levels in Different Populations of Human Subjects, file dd9e0c65-b950-1e9c-e053-3a05fe0a45ef
|
63
|
|
Mechanisms involved in childhood obesity-related bone fragility, file dd9e0c65-a974-1e9c-e053-3a05fe0a45ef
|
59
|
|
Bone Fragility in Turner Syndrome: Mechanisms and Prevention Strategies, file dd9e0c64-457f-1e9c-e053-3a05fe0a45ef
|
51
|
|
Irisin Serum Levels in Metabolic Syndrome Patients Treated with Three Different Diets: A Post-Hoc Analysis from a Randomized Controlled Clinical Trial, file dd9e0c65-4733-1e9c-e053-3a05fe0a45ef
|
49
|
|
Human myeloma cell lines induce osteoblast down-regulation of CD99 which is involved in osteoblast formation and activity, file dd9e0c63-5fd1-1e9c-e053-3a05fe0a45ef
|
48
|
|
Skeleton and glucose metabolism: a bone-pancreas loop, file dd9e0c63-3695-1e9c-e053-3a05fe0a45ef
|
47
|
|
Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: Crosstalk between the immune and bone systems, file dd9e0c64-d0a7-1e9c-e053-3a05fe0a45ef
|
25
|
|
High Sclerostin and Dickkopf-1 (DKK-1) serum levels in children and adolescents with type 1 diabetes mellitus, file dd9e0c66-b7ba-1e9c-e053-3a05fe0a45ef
|
21
|
|
Light/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease., file dd9e0c64-5753-1e9c-e053-3a05fe0a45ef
|
14
|
|
TRAIL effect on osteoclast formation in physiological and pathological conditions, file dd9e0c62-7656-1e9c-e053-3a05fe0a45ef
|
11
|
|
Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α, file dd9e0c64-4815-1e9c-e053-3a05fe0a45ef
|
10
|
|
null, file dd9e0c6c-8a4d-1e9c-e053-3a05fe0a45ef
|
9
|
|
null, file dd9e0c65-bc9c-1e9c-e053-3a05fe0a45ef
|
8
|
|
null, file dd9e0c67-2c7b-1e9c-e053-3a05fe0a45ef
|
8
|
|
Sclerostin stimulates angiogenesis in human endothelial cells, file dd9e0c64-12c1-1e9c-e053-3a05fe0a45ef
|
7
|
|
null, file dd9e0c66-a941-1e9c-e053-3a05fe0a45ef
|
7
|
|
Osteogenic differentiation of dental follicle stem cells., file dd9e0c63-10fc-1e9c-e053-3a05fe0a45ef
|
6
|
|
Monoclonal antibodies for treating osteoporosis, file dd9e0c64-e225-1e9c-e053-3a05fe0a45ef
|
6
|
|
The role of light (TNFSF14) on bone remodeling, file dd9e0c69-c186-1e9c-e053-3a05fe0a45ef
|
6
|
|
FSH and TSH in the regulation of bone mass: the pituitary/immune/bone axis, file dd9e0c62-597b-1e9c-e053-3a05fe0a45ef
|
5
|
|
Periodontal disease: linking the primary inflammation to bone loss, file dd9e0c64-47a0-1e9c-e053-3a05fe0a45ef
|
5
|
|
Irisin and musculoskeletal health, file dd9e0c64-c243-1e9c-e053-3a05fe0a45ef
|
5
|
|
A role of light as potential biomarker for progression of smoldering to symptomatic multiple myeloma, file dd9e0c65-47b1-1e9c-e053-3a05fe0a45ef
|
5
|
|
Irisin for care and prevention of osteoporosis, file dd9e0c69-ebba-1e9c-e053-3a05fe0a45ef
|
5
|
|
Myeloma cells suppress osteoblasts through sclerostin secretion, file dd9e0c63-10fa-1e9c-e053-3a05fe0a45ef
|
4
|
|
Integrated in vitro approaches to assess the bioaccessibility and bioavailability of silicon-biofortified leafy vegetables and preliminary effects on bone, file dd9e0c64-1337-1e9c-e053-3a05fe0a45ef
|
4
|
|
null, file dd9e0c64-de31-1e9c-e053-3a05fe0a45ef
|
4
|
|
Oxytocin is an Anabolic Bone Hormone, file dd9e0c64-ec76-1e9c-e053-3a05fe0a45ef
|
4
|
|
Deletion of the Transcription Factor PGC-1α in Mice Negatively Regulates Bone Mass, file dd9e0c65-7ead-1e9c-e053-3a05fe0a45ef
|
4
|
|
null, file dd9e0c65-c45f-1e9c-e053-3a05fe0a45ef
|
4
|
|
Irisin for care and prevention of osteoporosis, file dd9e0c69-9121-1e9c-e053-3a05fe0a45ef
|
4
|
|
null, file dd9e0c62-a09c-1e9c-e053-3a05fe0a45ef
|
3
|
|
The role of tnf-alpha and tnf superfamily members in the pathogenesis of calcific aortic valvular disease, file dd9e0c64-4fd9-1e9c-e053-3a05fe0a45ef
|
3
|
|
null, file dd9e0c64-50e3-1e9c-e053-3a05fe0a45ef
|
3
|
|
The genetic background and vitamin D supplementation can affect irisin levels in Prader–Willi syndrome, file dd9e0c6b-4dcb-1e9c-e053-3a05fe0a45ef
|
3
|
|
Irisin Role in Chondrocyte 3D Culture Differentiation and Its Possible Applications, file 95fcc197-5f7d-4763-8574-f1ebca33dd95
|
2
|
|
Irisin Modulates Inflammatory, Angiogenic, and Osteogenic Factors during Fracture Healing, file b4bba603-6ba0-4c02-a051-5c414e9bca48
|
2
|
|
TGFBETA1 triggers hepatocellular carcinoma invasiveness via ALPHA3BETA1 integrin, file dd9e0c62-44f6-1e9c-e053-3a05fe0a45ef
|
2
|
|
Improvement of Cortical Bone Mineral Density associated with physical exercise is exerted through the myokine Irisin., file dd9e0c62-8291-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c64-7c80-1e9c-e053-3a05fe0a45ef
|
2
|
|
High expression of TRAIL by osteoblastic differentiated dental pulp stem cells affects myeloma cell viability, file dd9e0c65-0b56-1e9c-e053-3a05fe0a45ef
|
2
|
|
High irisin levels are associated with better glycemic control and bone health in children with Type 1 diabetes, file dd9e0c65-4187-1e9c-e053-3a05fe0a45ef
|
2
|
|
Mechanisms of enhanced osteoclastogenesis in Alkaptonuria, file dd9e0c65-c099-1e9c-e053-3a05fe0a45ef
|
2
|
|
Myokines and Osteokines in the Pathogenesis of Muscle and Bone Diseases, file dd9e0c68-8b68-1e9c-e053-3a05fe0a45ef
|
2
|
|
null, file dd9e0c6b-591c-1e9c-e053-3a05fe0a45ef
|
2
|
|
Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice, file e0cc720f-fd16-4969-990d-c7b6e7f6027f
|
2
|
|
Irisin enhances osteoblast differentiation in vitro, file e929916b-0295-4387-b64e-a6f628cba2a3
|
2
|
|
Antidepressant Effect of Intermittent Long‐Term Systemic Administration of Irisin in Mice, file f5c212f1-88e7-4372-b31a-300877248d44
|
2
|
|
Osteoclastogenesis in children with 21-hydroxylase deficiency on long-term glucocorticoid therapy: the role of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin imbalance, file dd9e0c62-dba0-1e9c-e053-3a05fe0a45ef
|
1
|
|
High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment, file dd9e0c63-158d-1e9c-e053-3a05fe0a45ef
|
1
|
|
Osteoblasts display different responsiveness to TRAIL- induced apoptosis during their differentiation process, file dd9e0c63-15c6-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c63-5946-1e9c-e053-3a05fe0a45ef
|
1
|
|
Crosstalk Between Muscle and Bone Via the Muscle-Myokine Irisin, file dd9e0c63-b539-1e9c-e053-3a05fe0a45ef
|
1
|
|
The myokine Irisin recapitulates the effect of physical activity on bone and muscle tissues, file dd9e0c63-bd51-1e9c-e053-3a05fe0a45ef
|
1
|
|
The effects of bone pâté on human osteoblasts cell cultures, file dd9e0c64-4762-1e9c-e053-3a05fe0a45ef
|
1
|
|
null, file dd9e0c64-4772-1e9c-e053-3a05fe0a45ef
|
1
|
|
Soluble Decoy Receptor 3 (DcR3) modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients, file dd9e0c64-5daa-1e9c-e053-3a05fe0a45ef
|
1
|
|
THE ROLE OF LIGHT ON BONE REMODELING, file dd9e0c64-6fe6-1e9c-e053-3a05fe0a45ef
|
1
|
|
Irisin levels correlate with bone mineral density in soccer players, file dd9e0c64-b91e-1e9c-e053-3a05fe0a45ef
|
1
|
|
EVALUATION AND USEFULNESS OF OSTEOPROTEGERIN AND PRESEPSIN TITERS IN PATIENTS WITH SEPSIS: OUR PRELIMINARY EXPERIENCE, file dd9e0c64-e707-1e9c-e053-3a05fe0a45ef
|
1
|
|
The formation of osteoclasts in multiple myeloma bone disease patients involves the secretion of solubile decoy receptor 3, file dd9e0c64-f4ec-1e9c-e053-3a05fe0a45ef
|
1
|
|
An update on the role of RANKL–RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases, file dd9e0c66-c299-1e9c-e053-3a05fe0a45ef
|
1
|
|
Irisin prevents microgravity-induced impairment of osteoblast differentiation in vitro during the space flight CRS-14 mission, file dd9e0c68-dc7d-1e9c-e053-3a05fe0a45ef
|
1
|
|
Myokine Irisin and Its Effects Linking Bone and Muscle Function, file dd9e0c6a-a8f3-1e9c-e053-3a05fe0a45ef
|
1
|
|
Mechanisms of Altered Bone Remodeling in Multiple Myeloma, file dd9e0c6a-edf8-1e9c-e053-3a05fe0a45ef
|
1
|
|
FNDC5/Irisin System in Neuroinflammation and Neurodegenerative Diseases: Update and Novel Perspective, file dd9e0c6b-1961-1e9c-e053-3a05fe0a45ef
|
1
|
|
The myokine irisin promotes osteogenic differentiation of dental bud-derived mscs, file dd9e0c6b-6bec-1e9c-e053-3a05fe0a45ef
|
1
|
|
Mechanisms of enhanced osteoclastogenesis in girls and young women with Turner's Syndrome, file eee50c35-7941-4c1e-827c-edece2825291
|
1
|
| Totale |
1.380 |